FEDERATED HERMES, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,670,899
+3.0%
40,979
-2.1%
0.01%
+11.1%
Q2 2023$3,565,238
+475.5%
41,875
+459.4%
0.01%
+350.0%
Q1 2023$619,466
+0.3%
7,486
-4.6%
0.00%0.0%
Q4 2022$617,403
-11.8%
7,850
-17.1%
0.00%0.0%
Q3 2022$700,000
-4.9%
9,464
-16.2%
0.00%0.0%
Q2 2022$736,000
-97.5%
11,291
-97.6%
0.00%
-97.0%
Q1 2022$29,245,000
+287.2%
462,586
+224.8%
0.07%
+371.4%
Q4 2021$7,553,000
+968.3%
142,402
+1322.5%
0.01%
+1300.0%
Q3 2021$707,000
+72.9%
10,011
+63.3%
0.00%0.0%
Q2 2021$409,000
-63.5%
6,132
-39.2%
0.00%
-50.0%
Q1 2021$1,120,000
-10.0%
10,091
-3.7%
0.00%
-33.3%
Q4 2020$1,244,000
-74.0%
10,474
-80.9%
0.00%
-72.7%
Q3 2020$4,788,000
-30.2%
54,884
-28.3%
0.01%
-35.3%
Q2 2020$6,857,000
+339.3%
76,554
+388.7%
0.02%
+240.0%
Q1 2020$1,561,000
-85.8%
15,666
-83.7%
0.01%
-80.0%
Q4 2019$11,012,000
+1.5%
95,835
+11.4%
0.02%
-7.4%
Q3 2019$10,850,000
+436.1%
86,015
+411.5%
0.03%
+440.0%
Q2 2019$2,024,000
+3.0%
16,815
-25.2%
0.01%0.0%
Q1 2019$1,966,000
-84.6%
22,473
-82.4%
0.01%
-85.7%
Q4 2018$12,775,000
-32.3%
127,692
-22.5%
0.04%
-20.5%
Q3 2018$18,875,000
+19.0%
164,734
-6.8%
0.04%
-4.3%
Q2 2018$15,857,000
+49.2%
176,819
+21.7%
0.05%
+48.4%
Q1 2018$10,628,000
+15529.4%
145,268
+12358.7%
0.03%
Q4 2017$68,000
+25.9%
1,166
-2.6%
0.00%
Q3 2017$54,000
+8.0%
1,197
-6.0%
0.00%
Q2 2017$50,000
-2.0%
1,274
+1.3%
0.00%
Q1 2017$51,000
-12.1%
1,258
-12.6%
0.00%
Q4 2016$58,0000.0%1,440
-9.5%
0.00%
Q3 2016$58,000
+5.5%
1,591
-15.6%
0.00%
Q2 2016$55,000
-24.7%
1,886
-10.2%
0.00%
Q1 2016$73,000
+7.4%
2,1000.0%0.00%
Q4 2015$68,000
+1033.3%
2,100
+1113.9%
0.00%
Q4 2014$6,0000.0%173
-6.5%
0.00%
Q3 2014$6,000
-90.3%
185
-89.5%
0.00%
Q2 2014$62,000
-27.1%
1,757
-33.0%
0.00%
Q1 2014$85,000
+304.8%
2,621
+427.4%
0.00%
Q4 2013$21,0004970.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders